D. Storan

Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies

L. McHugh, Joseph Lavelle, D. Storan, 2022, Journal of clinical medicine.

Simultaneous Metastases of Adenocarcinoma of the Lung to the Small and Large Intestine

A. Fabre, G. Doherty, D. Storan, 2020, ACG case reports journal.

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

C. Lees, D. Franchimont, K. Farkas, 2020, Alimentary pharmacology & therapeutics.

Satisfaction with telemedicine-delivered inflammatory bowel disease care depends on disease activity, personality and economic factors

Anne M. Burke, M. Hamzawi, Joseph Lavelle, 2022, Frontline Gastroenterology.

DOP74 Effectiveness of dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy: A multicentre international cohort study

C. Lees, D. Franchimont, S. Vavricka, 2020 .

Clinical features and outcomes of appendiceal neuroendocrine tumours: 10 year audit from the Irish NET Centre of Excellence

N. Swan, S. Skehan, D. Storan, 2023, Journal of neuroendocrinology.

Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation

J. Sheridan, G. Cullen, E. Mcdermott, 2023, Frontline Gastroenterology.